[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"knee-pain\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:knee-pain":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,10,0,[8,47,77,104,125,154,178,211,236,266],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":31,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100646099","a-clinical-trial-to-investigate-the-efficacy-and-safety-of-a-plant-derived-cetylated-fatty-acids-cfa-on-knee-pain-and-stiffness-in-healthy-adults-with-persistent-knee-pain-100646099",false,"NCT07695714","A Clinical Trial to Investigate the Efficacy and Safety of a Plant-based Cetylated Fatty Acids (CFA) on Knee Pain and Stiffness in Healthy Adults With Persistent Knee Pain","A Randomized, Triple-blind, Placebo Controlled, Parallel Clinical Trial to Investigate the Efficacy and Safety of a Plant-based Cetylated Fatty Acids on Knee Pain and Stiffness in Healthy Adults With Persistent Knee Pain","Inclusion Criteria:\n\n1. Males \\& females between 35 and 75 years of age\n2. Females not of child-bearing potential, defined as those who have undergone a sterilization procedure (e.g. hysterectomy, bilateral oophorectomy, bilateral tubal ligation, complete endometrial ablation) or have been post-menopausal for at least 1 year prior to screening Or,\n\n   Individuals of child-bearing potential must have a negative baseline urine pregnancy test and agree to use a medically approved method of birth control for the duration of the study. All hormonal birth control must have been in use for a minimum of three months. Acceptable methods of birth control include:\n   * Hormonal contraceptives including oral contraceptives, hormone birth control patch (Ortho Evra), vaginal contraceptive ring (NuvaRing), injectable contraceptives (Depo-Provera, Lunelle), or hormone implant (Norplant System)\n   * Double-barrier method\n   * Intrauterine devices\n   * Non-heterosexual lifestyle and agrees to use contraception if planning on changing to heterosexual partner(s)\n   * Vasectomy of partner at least 6 months prior to screening\n   * Abstinence and agrees to use contraception if planning on becoming sexually active during the study\n3. A history of symptomatic knee discomfort, defined as experiencing pain in the target knee on most days of the month (≥ 15 days\u002Fmonth) for at least the past 3 months\n4. A KOOS Pain Subscale score ≥25 and ≤75\n5. Target knee is the primary source of lower-limb pain limiting walking and daily function, as confirmed by the QI\n6. A KOOS Function in daily living (ADL) score ≥25 and ≤ 80\n7. Travel less than 85% of predicted distance on the 6MWT as calculated using the Enright and Sherrill equation at screening (15)\n8. Agrees to refrain from taking any pain relievers during the study, except acetaminophen as a rescue medication specified by the study site\n9. Agrees to refrain from taking rescue medication for 48 hours prior to study visits\n10. Willingness and ability to complete questionnaires, functional tests, records, and diaries associated with the study and to complete all clinic visits\n11. Agrees to maintain current lifestyle habits (diet, physical activity, medications, supplements, and sleep) as much as possible throughout the study\n12. Provided voluntary, written, informed consent to participate in the study\n13. Healthy as determined by medical history as assessed by the Qualified Investigator (QI)\n\nExclusion Criteria:\n\n1. Individuals who are pregnant, breast feeding, or planning to become pregnant during the study\n2. Allergy, sensitivity, intolerance, or dietary restriction preventing consumption of investigational product, placebo, or rescue medication ingredients\n3. Individuals with a Body Mass Index (BMI) \\>34.9\n4. Prior clinician diagnosis (confirmed via x-ray) of knee OA or evidence of OA (e.g. severe deformity\u002Fconstant pain) or confounding pain condition such as fibromyalgia\n5. Intra-articular injection of corticosteroids or hyaluronic acid in either knee within 3 months prior to the Baseline visit\n6. Change in knee pain\u002Fstiffness\u002Fmobility treatment (e.g. physical therapy, braces, orthotics) in the past two months, as assessed by the QI\n7. Use of any assistive device for walking\u002Fmobility\n8. Any knee surgery within the past 6 months, or planned knee surgery within the study duration\n9. Individuals with muscle or skeletal disorders or other physical or gait disorders that limit mobility\u002Fwalking beyond what may be caused by the impacted knee, as assessed by the QI\n10. History of knee replacement\n11. Unstable metabolic disease or chronic diseases as assessed by the QI\n12. Current or history of any significant diseases of the gastrointestinal tract as assessed by the QI\n13. Unstable hypertension. Treatment on a stable dose of medication for at least 3 months will be considered by the QI\n14. Type I or Type II and controlled Type II diabetes\n15. Significant cardiovascular event in the past 6 months. Participants with no significant cardiovascular event on stable medication may be included after assessment by the QI on a case-by-case basis\n16. History of or current diagnosis with kidney and\u002For liver diseases as assessed by the QI on a case-by-case basis, with the exception of history of kidney stones in participants who are symptom free for 6 months\n17. Self-reported confirmation of current or pre-existing thyroid condition. Treatment on a stable dose of medication for at least 3 months will be considered by the QI\n18. Major surgery in the past 3 months or individuals who have planned surgery during the course of the study. Participants with minor surgery will be considered on a case-by-case basis by the QI\n19. Cancer, except skin basal cell carcinoma completely excised with no chemotherapy or radiation with a follow up that is negative. Volunteers with cancer in full remission for more than five years after diagnosis are acceptable\n20. Individuals with an autoimmune disease or are immune compromised as assessed by the QI\n21. Self-reported confirmation of a HIV-, Hepatitis B- and\u002For C-positive diagnosis as assessed by the QI\n22. Use of prescription medical cannabinoid products\n23. Chronic use of cannabinoid products (\\>2 times\u002Fweek). Occasional users will be required to washout and abstain for the duration of the study period\n24. Regular use of tobacco or nicotine products in the past six months, as assessed by the QI. Occasional users will be required to washout and abstain for the duration of the study period\n25. Alcohol intake average of \\>2 standard drinks per day as assessed by the QI\n26. Alcohol or drug abuse within the last 12 months\n27. Current use of prescribed and\u002For over-the-counter (OTC) medications, supplements, and\u002For consumption of food\u002Fdrinks that may impact the efficacy and safety of the investigational product\n28. Participation in other clinical research studies 30 days prior to baseline, as assessed by the QI\n29. Individuals who are unable to give informed consent\n30. Any other condition or lifestyle factor, that, in the opinion of the QI, may adversely affect the participant's ability to complete the study or its measures or pose significant risk to the participant",true,"ALL","35 Years","75 Years",{"count":21,"type":22},80,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this clinical trial is to investigate the efficacy and safety of plant-derived cetylated fatty acids (CFA) on joint health and mobility in adults with persistent knee pain. The main question it aims to answer is what is the change from baseline to day 42 in knee joint health, as assessed by the KOOS pain sub-scale scores, between plant-derived cetylated fatty acids (CFA) and placebo? Researchers will compare plant-derived cetylated fatty acids (CFA) with placebo to evaluate its effects on joint health, mobility, pain, and stiffness. Participants will be asked to:\n\n* Consume plant-derived cetylated fatty acids (CFA) or placebo daily from Day 1 until the day before the end-of-study visit\n* Have height, weight, heart rate, and blood pressure measurements taken\n* Complete the Knee injury and Osteoarthritis Outcome Score (KOOS) questionnaire\n* Complete the 6-Minute Walk Test (6MWT)\n* Complete the 30 seconds chair sit to stand test\n* Complete the pain and stiffness Likert scale\n* Complete the subject treatment diary daily",[28,29,30],"Joint Health","Mobility","Knee Pain",[28,29,30,32,33],"Stiffness","Cetylated Fatty Acids","NOT_YET_RECRUITING","2026-08-14",{"date":37,"type":38},"2026-08-18","ACTUAL",{"date":40,"type":22},"2026-08",{"date":42,"type":22},"2027-02",{"name":44,"class":45},"Everwell Health","INDUSTRY",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":17,"minAge":55,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":23,"phases":59,"briefSummary":60,"conditions":61,"keywords":65,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":46},"100648103","mikhled-knee-exercise-program-with-and-without-stecco-fascial-manipulation-effect-in-patellofemoral-pain-syndrome-100648103","NCT07716163","Mikhled Knee Exercise Program With and Without Stecco Fascial Manipulation Effect in Patellofemoral Pain Syndrome","Comparative Effects of the Mikhled Knee Exercise Program With and Without Stecco Fascial Manipulation on Pain, Range of Motion, and Functional Outcomes in Patellofemoral Pain Syndrome","MKEP","Inclusion Criteria:\n\n* Male and female participants between the ages of 25-45 years (16)\n* Diffused anterior knee pain for at least 8 weeks (16)\n* Pain exacerbated by climbing stairs, prolonged sitting, walking, running, squatting, knee flexion, and isometric quadriceps contraction (14).\n* Patients had never received Stecco fascial manipulation and MKEP before.\n\nExclusion Criteria:\n\n* Tendonitis\n* Osgood-Schlatter syndrome\n* OA\n* Fracture\n* Patellar sublaxation or dislocation\n* Previous history of surgery\n* Meniscus or ligament damage\n* Heart diseases\n* Neurological deficits\n* Pregnancy","25 Years","45 Years",{"count":58,"type":22},58,[25],"To compare the effects of the Mikhled Knee Exercise Program with and without Stecco Fascial Manipulation on pain, range of motion, and functional outcomes Patellofemoral Pain Syndrome.",[30,62,63,64],"Patellofemoral Pain Syndrome","Patellofemoral Pain (PFPS)","Fascial Manipulation",[66],"Fascia, Manipulation, Pain, Patellofemoral pain, Range of motion","2026-07-16",{"date":69,"type":38},"2026-07-21",{"date":71,"type":22},"2026-07-01",{"date":73,"type":22},"2026-09-01",{"name":75,"class":76},"Riphah International University","OTHER",{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":83,"eligibilityCriteria":84,"healthyVolunteers":11,"sex":17,"minAge":85,"maxAge":4,"enrollmentInfo":86,"targetDuration":4,"studyType":88,"phases":4,"briefSummary":89,"conditions":90,"keywords":4,"overallStatus":94,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":46},"100639070","fdg-petmri-imaging-of-patellofemoral-joint-osteoarthritis-100639070","NCT07625150","FDG PET\u002FMRI Imaging of Patellofemoral Joint Osteoarthritis","Understanding Painful Inflammation in Patellofemoral Joint OA Using [18F] FDG","FDG-PFJOA","Inclusion Criteria:\n\n* Adult with the capacity to give informed consent\n* Ability to perform 25 single-leg squats\n* No traumatic knee injuries\u002Fsurgeries since last visit for the parent study (IRB #21-34763)\n* No investigational drugs since last visit for the parent study (IRB #21-34763)\n* No contraindications to MRI or PET tracer since last visit for the parent study (IRB #21-34763)\n* Not taking steroid injections\n* Not pregnant\n* Additional inclusion criteria for healthy volunteers: Minimal pain (VAS=0-1) during a series of 25 single-leg squats on one or both legs\n\nExclusion Criteria:\n\n* Inability to consent for themselves\n* Inability to perform 25 single-leg squats with the study leg\n* New traumatic knee injuries\u002Fsurgeries since last visit for the parent study (IRB #21-34763)\n* Taking investigational drugs since last visit for the parent study (IRB #21-34763)\n* New contraindications to MRI or PET tracer since last visit for the parent study (IRB #21-34763)\n* Taking steroid injections\n* Pregnant\n* Diabetic\n* Additional exclusion criteria for healthy volunteers: VAS of 2 or greater during a series of 25 single-leg squats on both legs","18 Years",{"count":87,"type":22},50,"OBSERVATIONAL","This project aims to develop an \\[18F\\] fluorodeoxyglucose (FDG) positron emission tomography (PET) \u002F magnetic resonance imaging (MRI) method to locate the painful inflammation in PFJ OA associated with joint loading. \\[18F\\] FDG PET\u002FMRI is an emerging pain imaging approach with enhanced sensitivity to painful hypermetabolic inflammation through evaluation of intracellular glucose utilization rate via (\\[18F\\]FDG PET) and fine anatomy details (MRI). The investigative group has shown its promise in revealing previously unidentified or unspecified pain generators in various musculoskeletal pain conditions. The investigators have also demonstrated the feasibility of visualizing the structural changes between unloaded and loaded knee joints with MRI, which can be easily adopted in the current PET\u002FMRI setting. The main challenge in the proposed \\[18F\\]FDG PET\u002FMRI approach is to differentiate the normal uptake of FDG for metabolic changes by weight-bearing from abnormal changes indicating eventual pain aggravation by weight-bearing and knee-flexion. The investigators have garnered the following two aims to validate the proposed method by comparing unloaded and loaded knee imaging results between PFJ OA pain patients and asymptomatic, matched controls.",[91,92,30,93],"Patellofemoral Osteoarthritis","Knee Osteoarthritis","Inflamation","RECRUITING","2026-06-01",{"date":97,"type":38},"2026-06-04",{"date":99,"type":38},"2025-02-19",{"date":101,"type":22},"2028-02",{"name":103,"class":76},"University of California, San Francisco",{"id":105,"slug":106,"hasResults":11,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":4,"eligibilityCriteria":110,"healthyVolunteers":11,"sex":17,"minAge":85,"maxAge":4,"enrollmentInfo":111,"targetDuration":4,"studyType":23,"phases":113,"briefSummary":114,"conditions":115,"keywords":4,"overallStatus":94,"whyStopped":4,"lastUpdateSubmitDate":116,"lastUpdatePostDateStruct":117,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":122,"locationsCount":124},"100605147","genicular-nerve-block-for-knee-pain-in-the-ed-100605147","NCT07158736","Genicular Nerve Block for Knee Pain in the ED","Ultrasound-Guided Genicular Nerve Block for Knee Pain in the Emergency Department: A Randomized Controlled Trial","Inclusion Criteria:\n\n* Atraumatic knee pain\n* \\>17 years age\n* X-ray of the knee obtained in the ED\n* Initial pain score (numeric rating scale) 5-10\n\nExclusion Criteria:\n\n* Fracture or dislocation on x-ray\n* large knee joint effusion identified on x-ray\n* allergy or contraindication to local anesthetics\n* History of local anesthetic systemic toxicity after receiving local anesthetics\n* Pregnancy\n* Incarcerated\n* History of knee replacement of affected knee\n* Concern for septic joint\n* Overlying cellulitis\n* Hemodynamic instability\n* Altered mental status or inability to consent for procedure.",{"count":112,"type":22},34,[25],"Patient with atraumatic knee pain without a large knee effusion on x-ray will be randomized to receive either a genicular nerve block (GNB) or standard of care in the emergency department.",[30],"2026-02-11",{"date":118,"type":38},"2026-02-12",{"date":120,"type":38},"2025-08-06",{"date":73,"type":22},{"name":123,"class":76},"University of Pennsylvania",4,{"id":126,"slug":127,"hasResults":11,"nctId":128,"briefTitle":129,"officialTitle":130,"acronym":4,"eligibilityCriteria":131,"healthyVolunteers":11,"sex":17,"minAge":85,"maxAge":4,"enrollmentInfo":132,"targetDuration":4,"studyType":23,"phases":134,"briefSummary":135,"conditions":136,"keywords":141,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":145,"lastUpdatePostDateStruct":146,"startDateStruct":148,"completionDateStruct":150,"leadSponsor":152,"locationsCount":46},"100620282","mobile-app-assisted-home-exercise-for-musculoskeletal-disorders-100620282","NCT07355595","Mobile App-Assisted Home Exercise for Musculoskeletal Disorders","The Effect of the Mobile App-Assisted Home Exercise Program on Clinical Outcomes in Patients With Musculoskeletal Disorders","Inclusion Criteria:\n\n* Aged 18 years and above\n* Presenting with musculoskeletal disorders leading to pain in the neck, shoulder, low back, or knee\n* Scoring 3 or higher on the Numeric Pain Rating Scale\n\nExclusion Criteria:\n\n* Diagnosis of malignant tumors\n* Presence of serious systemic or neurological conditions that may interfere with assessment or treatment, such as uncontrolled hypertension, serious cardiac diseases, or Parkinson's disease\n* Inability to use a mobile smartphone\n* Pregnancy",{"count":133,"type":22},30,[25],"Overview This study evaluates the effectiveness of a dedicated mobile health (mHealth) application in supporting home exercise programs for patients with musculoskeletal disorders, such as neck, shoulder, back, or knee pain. The research aims to address the widespread challenge of low patient adherence to unsupervised home-based exercises.\n\nStudy Design The project employs a dual-methodology approach:\n\nClinical Trial: 30 participants presenting with neck, shoulder, back, or knee pain will be randomly assigned to either an app-assisted group or a traditional home exercise group. Both groups will undergo 4 weeks of physiotherapy. The study will compare pain intensity, physical function, and exercise adherence between the two cohorts.\n\nRetrospective Analysis: To complement the trial, the study will analyze a large-scale database containing approximately 700,000 anonymized real-world data entries. This analysis aims to observe real-time pain fluctuations before and after exercise sessions within routine clinical settings.\n\nGoal The primary objective is to determine if integrating mHealth technology into traditional rehabilitation can enhance clinical outcomes and improve patient adherence to home-based exercise routines.",[137,138,139,140,30],"Musculoskeletal Disorders","Low Back Pain","Neck Pain","Shoulder Pain",[142,143,144],"e-Health","Mobile Applications","Home Exercise Program","2026-01-12",{"date":147,"type":38},"2026-01-21",{"date":149,"type":22},"2026-01-15",{"date":151,"type":22},"2026-09-15",{"name":153,"class":76},"National Yang Ming Chiao Tung University",{"id":155,"slug":156,"hasResults":11,"nctId":157,"briefTitle":158,"officialTitle":158,"acronym":159,"eligibilityCriteria":160,"healthyVolunteers":11,"sex":17,"minAge":161,"maxAge":4,"enrollmentInfo":162,"targetDuration":163,"studyType":88,"phases":4,"briefSummary":164,"conditions":165,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":169,"lastUpdatePostDateStruct":170,"startDateStruct":172,"completionDateStruct":174,"leadSponsor":176,"locationsCount":4},"100611338","efficacy-and-safety-of-endovenous-ablation-for-relief-of-knee-pain-in-elderly-patients-with-lower-extremity-varicose-veins-a-prospective-observational-study-100611338","NCT07239284","Efficacy and Safety of Endovenous Ablation for Relief of Knee Pain in Elderly Patients With Lower Extremity Varicose Veins: A Prospective Observational Study","EVA-Knee-Elder","Inclusion Criteria:\n\nAdults aged ≥80 years. Clinical diagnosis of lower limb varicose veins with documented venous reflux on duplex ultrasound (CEAP C2-C4).\n\nPresence of knee pain lasting ≥4 weeks prior to enrollment, confirmed by patient-reported VAS\u002FNRS ≥3 at baseline.\n\nPlanned to undergo standard endovenous treatment (radiofrequency ablation, endovenous laser ablation, or equivalent).\n\nAbility to provide informed consent and complete study questionnaires.\n\nExclusion Criteria:\n\nPrior surgery or endovenous ablation for varicose veins in the same limb. History of inflammatory arthritis (e.g., rheumatoid arthritis, gout) or other systemic rheumatologic disease.\n\nRecent acute knee injury (ligament, meniscus, fracture) within 6 months. Prior knee replacement or major knee surgery. Recent intra-articular injection or arthroscopy (\\\u003C3 months). Known deep vein thrombosis or history of pulmonary embolism within the past 6 months.\n\nSevere peripheral arterial disease (ABI \\\u003C0.8). Pregnancy or breastfeeding. Inability to comply with follow-up schedule or complete questionnaires.","80 Years",{"count":87,"type":22},"6 Months","Lower extremity varicose veins (LEVV) are common among elderly patients and can cause leg heaviness, pain, and swelling. In some older adults, venous congestion may contribute to knee or peri-knee pain, which is often misattributed to degenerative joint disease alone. Evidence on whether varicose vein treatment can relieve knee pain in very elderly patients (aged 80 years or older) is limited.\n\nThis prospective cohort study aims to evaluate the effectiveness and safety of endovenous ablation (EVA) for improving knee pain in elderly patients with symptomatic varicose veins. The study will include participants aged 80 years or older who present with both lower extremity varicose veins and knee joint pain. Eligible patients will undergo endovenous thermal ablation (radiofrequency or endovenous laser ablation) as the primary intervention.\n\nParticipants will be assessed at baseline, 1 month, 3 months, 6 months, and 12 months after treatment. The primary outcome is the change in knee pain intensity measured by the Visual Analog Scale (VAS) from baseline to 6 months. Secondary outcomes include changes in knee joint function (assessed by the Western Ontario and McMaster Universities Osteoarthritis Index \\[WOMAC\\] or Knee Injury and Osteoarthritis Outcome Score \\[KOOS\\]), venous clinical severity score (VCSS), limb heaviness, quality of life (assessed by EQ-5D), and procedure-related complications.\n\nSafety will be evaluated by recording peri-procedural adverse events, including deep vein thrombosis, skin burns, nerve injury, and postoperative infection. The study will also analyze whether preexisting osteoarthritis, venous reflux severity, or body mass index (BMI) affect the magnitude of pain improvement.\n\nThe hypothesis is that endovenous ablation improves knee pain in elderly patients by reducing venous congestion around the knee and improving venous return. This study will help clarify whether treating varicose veins can provide additional benefits for knee pain and mobility in patients aged 80 years and older.",[166,167,30,92,168],"Varicose Veins of Lower Limb","Chronic Venous Insufficiency, CVI","Elderly Patients","2025-11-16",{"date":171,"type":38},"2025-11-20",{"date":173,"type":22},"2025-12-10",{"date":175,"type":22},"2027-07-10",{"name":177,"class":76},"Chengdu University of Traditional Chinese Medicine",{"id":179,"slug":180,"hasResults":11,"nctId":181,"briefTitle":182,"officialTitle":183,"acronym":4,"eligibilityCriteria":184,"healthyVolunteers":11,"sex":17,"minAge":85,"maxAge":4,"enrollmentInfo":185,"targetDuration":4,"studyType":23,"phases":187,"briefSummary":188,"conditions":189,"keywords":190,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":202,"lastUpdatePostDateStruct":203,"startDateStruct":205,"completionDateStruct":206,"leadSponsor":208,"locationsCount":4},"100609310","validity-and-reliability-of-video-based-functional-physiotherapy-assessment-of-subacute-knee-injuries-100609310","NCT07212920","Validity and Reliability of Video-Based Functional Physiotherapy Assessment of Subacute Knee Injuries","Physiotherapeutic Function-Based Assessment and Diagnosis of Subacute Knee Injuries During Physical or Video-Based Consultations - A Validity and Reliability Study","Inclusion Criteria:\n\n* Age 18 years or older\n* Subacute knee symptoms (onset more than one week ago but less than three months ago)\n* Fulfillment of Ottawa Knee Rule criteria to exclude fractures:\n\nA) Able to bear weight for at least four steps both immediately after injury and at the time of assessment (limping allowed) B) Able to flex the knee to 90 degrees C) No tenderness over the fibular head or patella\n\n* Sufficient proficiency in written and spoken Swedish to complete forms and describe symptoms; no need for interpreter\n* Access to digital technology (e.g., computer or smartphone)\n\nExclusion Criteria:\n\n* Prior assessment for current knee symptoms (by rehab clinic, physician, emergency care, or urgent care)\n* Knee or hip replacement surgery within the past year\n* Other knee surgeries (ACL, meniscus, ligament) within the past year\n* Inability to walk independently, with or without walking aids",{"count":186,"type":22},138,[25],"This study aims to validate a function-based physiotherapy assessment for subacute knee pain without using specific knee tests. Assessments are conducted either in-person or via video consultations in primary care. The study also compares the reliability of digital versus physical assessments to determine if video-based evaluations can provide sufficient diagnostic support and guide treatment decisions.\n\nThe main questions this study aims to answer are:\n\n1. Is a function-based knee assessment without specific knee tests valid compared to traditional in-person diagnostics using specific tests?\n2. Is a video-based assessment based on history and function-based knee assessment without specific knee tests as valid and reliable as an in-person function-based knee assessment?\n3. What is the interrater agreement of function-based knee assessments conducted via video compared to those conducted in person?",[30],[191,192,193,194,195,196,197,198,199,200,201],"Physiotherapy","Physical therapy","Assessment","Diagnosis","Digital care","Telemedicine","Knee pain","Anterior cruciate ligament","Knee osteoarthritis","Meniscus tears","Collateral ligament","2025-10-01",{"date":204,"type":38},"2025-10-08",{"date":202,"type":22},{"date":207,"type":22},"2026-12-31",{"name":209,"class":210},"Vastra Gotaland Region","OTHER_GOV",{"id":212,"slug":213,"hasResults":11,"nctId":214,"briefTitle":215,"officialTitle":216,"acronym":4,"eligibilityCriteria":217,"healthyVolunteers":11,"sex":17,"minAge":85,"maxAge":218,"enrollmentInfo":219,"targetDuration":4,"studyType":23,"phases":221,"briefSummary":222,"conditions":223,"keywords":4,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":227,"lastUpdatePostDateStruct":228,"startDateStruct":230,"completionDateStruct":232,"leadSponsor":234,"locationsCount":46},"100582285","effects-of-short-foot-exercise-on-knee-pain-muscle-tone-balance-and-quality-of-life-in-flexible-flatfoot-patients-100582285","NCT06861322","Effects of Short Foot Exercise on Knee Pain, Muscle Tone, Balance, and Quality of Life in Flexible Flatfoot Patients","The Effects of Short Foot Exercises on Knee Muscle Tone, Knee Pain and Function, Balance, and Quality of Life in Patients with Flexible Flat Foot with Knee Pain","Inclusion Criteria:\n\n* BMI (Body Mass Index): If between 18 and 25 kg\u002Fm²\n* Litigation period: If knee pain lasted for more than 6 weeks\n* Navicular drop test: If it was 10 mm or more\n* Numerical assessment scale: If knee pain was 4 or more\n* Health status: If you are a person without health problems and are trying to participate in the experiment\n\nExclusion Criteria:\n\n* History of knee surgery: If you have had knee surgery\n* Treatment history: If you have received physical therapy for knee pain in the 4 weeks before the start of the study\n* Mental status: If you have a psychological disorder that may interfere with your participation in the study\n* Injury status: If you have a current serious injury affecting the lower extremity joints and foot\n* Lower extremity alignment abnormalities and specific conditions: If you have structural flat foot, scoliosis\n* Diseases and other conditions: If you have diabetes, rheumatoid arthritis, or menopause\n* Neurological disorders: If you have experienced a neurological disorder within the past 6 months","65 Years",{"count":220,"type":22},44,[25],"This study was a clinical trial to investigate the effects of Short Foot Exercise (SFE) and standard physical therapy on knee muscle tone, knee pain and function, balance ability, and quality of life in adults with flexible flat feet and knee pain.",[224,30,225,226],"Flexible Flatfoot","Balance Impairment","Quality of Life (QOL)","2025-02-28",{"date":229,"type":38},"2025-03-06",{"date":231,"type":22},"2025-03-02",{"date":233,"type":22},"2025-06-30",{"name":235,"class":76},"Sahmyook University",{"id":237,"slug":238,"hasResults":11,"nctId":239,"briefTitle":240,"officialTitle":241,"acronym":4,"eligibilityCriteria":242,"healthyVolunteers":11,"sex":17,"minAge":85,"maxAge":161,"enrollmentInfo":243,"targetDuration":4,"studyType":88,"phases":4,"briefSummary":245,"conditions":246,"keywords":250,"overallStatus":94,"whyStopped":4,"lastUpdateSubmitDate":257,"lastUpdatePostDateStruct":258,"startDateStruct":260,"completionDateStruct":262,"leadSponsor":264,"locationsCount":46},"100491090","cryoneurolysis-for-knee-and-shoulder-pain-in-an-inpatient-setting-100491090","NCT05674604","Cryoneurolysis for Knee and Shoulder Pain in an Inpatient Setting","Cryoneurolysis as a Drug Free Novel Treatment for Knee and Shoulder Pain Impairing Inpatient Neurological Rehabilitation","Inclusion Criteria:\n\n1. Adult inpatients at any hospital in the Greater Victoria Area or referred to Victoria General hospital for rehabilitation with the chief complaint of an acute neurological condition (within sixteen weeks) including but not limited to stroke and traumatic brain injury. People that have had a stroke or neurological event within sixteen weeks but have been discharged to outpatient rehab at Victoria General Hospital are also candidates\n2. In addition to their chief complaint, are also affected by one or both of the following\n\n   1. Hemiplegic shoulder pain,\n   2. Knee pain due to osteoarthritis\n3. Patients who are already candidate for cryoneurolysis.\n4. Ability to attend testing sessions, comply with testing protocols and provide either written or verbal informed consent. If necessary, a witness will be asked to sign the consent form and confirm the participant signature. For those patients who do not have the capacity to sign the consent form(Based on evaluation by PI or the recorded assessment by their physician in their medical charts) the designated care provider or family member will be asked to sign the ICF on behalf of them. Evaluation of the capacity to understand and communicate are part of routine assessment and are done routinely and each visit by physicians.\n5. Able to understand and complete study-related questionnaires (must be able to understand and speak English or have access to an appropriate interpreter as judged by the investigator).\n\nExclusion Criteria:\n\n1. Have undergone any previous peripheral nerve procedures in their affected side, for the treatment of spasticity or pain. Relevant treatments included but not limited to previous cryoneurolysis, previous chemical neurolysis, neurectomy or arthroplasty.\n2. Patients who received botulinum toxin in the past 4 months in the same targeted muscles for cryoneurolysis",{"count":244,"type":22},25,"The purpose of the study is to measure the outcomes of a standard care, an ultrasound guided mini-invasive percutaneous procedure, performed on recent stroke patients on reduces pain, increases function \\& quality of life\n\nThe primary objective of the project is to reduce shoulder and\u002For knee pain in patients who have had a stroke so that they can more readily engage in rehabilitation.\n\nSecondary objectives are to reduce analgesic medications, increase independence and improve range of motion, to promote non-drug treatment measures in the medical toolkit, and to include an interdisciplinary care team in patient selection for interventions.",[140,30,247,248,249],"Spasticity","Pain","Acute Stroke",[251,252,253,254,255,256],"Cryoneurolysis","shoulder pain","knee pain","spasticity","acute stroke","In-patient setting","2024-06-12",{"date":259,"type":38},"2024-06-14",{"date":261,"type":38},"2022-10-10",{"date":263,"type":22},"2024-12",{"name":265,"class":76},"Vancouver Island Health Authority",{"id":267,"slug":268,"hasResults":11,"nctId":269,"briefTitle":270,"officialTitle":271,"acronym":4,"eligibilityCriteria":272,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":273,"targetDuration":4,"studyType":88,"phases":4,"briefSummary":275,"conditions":276,"keywords":279,"overallStatus":94,"whyStopped":4,"lastUpdateSubmitDate":283,"lastUpdatePostDateStruct":284,"startDateStruct":286,"completionDateStruct":288,"leadSponsor":290,"locationsCount":46},"100228914","the-effect-of-integrated-cam-treatment-in-hospitalized-patients-100228914","NCT02257723","The Effect of Integrated CAM Treatment in Hospitalized Patients","The Effect of Integrated CAM Treatment in Patients Hospitalized at a Korean Medicine Hospital","Inclusion Criteria:\n\n* Patients hospitalized due to spine or joint diseases\n\nExclusion Criteria:\n\n* Main complaint other than back pain, radiating leg pain, neck pain, radiating arm pain, knee pain or shoulder pain\n* Cause of pain non-related to spine, joint or soft tissue; for example, spinal tumors, pregnancy, urolithiasis, etc.\n* Refusal to provide the information needed for clinical research",{"count":274,"type":22},100000,"This study investigates the effect of hospital-based intensive non-surgical treatment in musculoskeletal patients admitted to an integrated hospital that offers both complementary and alternative medicine (CAM) and conventional medicine treatment.",[138,139,30,140,277,278],"Intervertebral Disc Herniation","Spinal Stenosis",[280,281,282],"Inpatient care","Complementary and alternative medicine","Integrated medicine","2023-09-26",{"date":285,"type":38},"2023-09-28",{"date":287,"type":38},"2012-01",{"date":289,"type":22},"2040-12",{"name":291,"class":76},"Jaseng Hospital of Korean Medicine"]